Elizabeth Olek, SVP and CMO at Achillion Pharmaceuticals, holds 193.28K shares in Kronos Bio (Ticker: KRON), holds 2.00K shares in Achillion Pharmaceuticals (Ticker: ~ACHN). Most recently, Elizabeth Olek Sold ― shares of Kronos Bio on Feb 23, 2024 for an estimated value of 7.74K.